American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
e Information collected at screening on comorbidities was based on medical history and included: type 2 diabetes (STEP 2 only), dyslipidaemia, hypertension, coronary artery disease, cerebrovascular disease, obstructive sleep apnoea, impaired glucose metabolism (not included for STEP 2), reproductive system disorders, liver disease, kidney disease, osteoarthritis, gout, thyroid disease (STEP 3 only) and asthma or chronic obstructive pulmonary disease
nej.md/44U3slP A1c 7.8%, GFR 47 24.9% sulfonylureas, 61% insulin, but only 15.5% on #SGLT2 ncbi.nlm.nih.gov/pmc/articles/P Well we may have more questions than answer:s: #sglt2i vs
For more details, refer to Mayo Clinic Semaglutide Information
Transparency around pricing, service scope, and provider authority further supports informed decision-making